The global neurostimulation market is on a trajectory of impressive expansion, with projections indicating a rise from USD 6,221.2 million in 2023 to an estimated USD 15,417.4 million by 2033. This ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Credit: Neurovalens. Modius Sleep is an electrical vestibular nerve stimulator that sends signals to a neural pathway that connects to the hypothalamus. Modius Sleep lowered Insomnia Severity ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

24, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the Affera™ Mapping and ...

Image credit: Lightspring / Shutterstock. Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen ...

Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen-3 Halo headset, as an at-home ...

Summary: Researchers have developed an 8-channel neural stimulation chip that delivers exponential waveforms with 98% power efficiency, marking a breakthrough for brain-machine interfaces and neural ...